15 резултата
BACKGROUND OF THE INVENTION
Stroke is predicted to affect more than 600,000 people in the United States a year. In a 1999 report, over 167,000 people died from strokes, with a total mortality of 278,000. In 1998, 3.6 billion was paid to just those Medicare beneficiaries that were discharged from
FIELD OF THE INVENTION
The present invention is directed to a portable cooling assembly for cooling a patient. The invention is particularly directed to an assembly including a cooling unit coupled to a garment for cooling a patient.
BACKGROUND OF THE INVENTION
There are situations where a person
FIELD OF THE INVENTION
The present invention is directed to a portable cooling assembly for cooling a patient. The invention is particularly directed to an assembly including a cooling unit coupled to a garment for cooling a patient.
BACKGROUND OF THE INVENTION
There are situations where a person
BACKGROUND OF THE INVENTION
The present invention relates to the treatment of certain conditions using a compound of formula I or II, or a pharmaceutically acceptable salt thereof, as defined below. Specifically, the compounds of formulas I and II, and their pharmaceutically acceptable salts, as
FIELD OF THE INVENTION
The present invention generally relates to medical devices useful in 1) extending the critical period of brain death to allow for resuscitation in cardiac arrest, exsanguination, and other causes of circulatory arrest; and 2) reducing and preventing brain injury or spinal cord
BACKGROUND OF THE INVENTION
The present invention is novel compounds which are 4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidine substituted 1,2,4- and 1,3,4-thiadazoles and oxadiazoles, and 1,2,4-triazoles, and pharmaceutically acceptable acid addition or base salts thereof, pharmaceutical
FIELD OF THE INVENTION
The present invention relates to the treatment of fever using a nonopioid analgesic and an endothelin antagonist. More particularly, the present invention relates to a method of potentiating the antipyretic action of a nonopioid analgesic, like acetaminophen, in a mammal by
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims priority to and is a national phase application under 35 USC .sctn.371 of International application number PCT/EP2008/068114, filed Dec. 19, 2008, which claims priority to Irish patent application serial number 2007/0934, filed on Dec.
BACKGROUND OF THE INVENTION
The present invention is novel compounds which are 4,6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidine substituted 1,2,4- and 1,3,4-thiadazoles and oxadiazoles, and 1,2,4-triazoles, and pharmaceutically acceptable acid addition or base salts thereof, pharmaceutical
FIELD OF THE INVENTION
The present invention relates generally to coolers for heat exchange catheters.
BACKGROUND OF THE INVENTION
The present assignee has introduced heat exchangers that cool (and in some cases heat) saline that is sent in a closed loop through an indwelling heat exchange catheter
BACKGROUND OF THE INVENTION
The present invention comprises a new class of compounds useful in treating diseases, such as TNF-.alpha., IL-1.beta., IL-6 and/or IL-8 mediated diseases and other maladies, such as pain and diabetes. In particular, the compounds of the invention are useful for the
BACKGROUND OF THE INVENTION
The present invention comprises a new class of compounds useful in treating diseases, such as TNF-.alpha., IL-1.beta., IL-6 and/or IL-8 mediated diseases and other maladies, such as pain and diabetes. In particular, the compounds of the invention are useful for the
BACKGROUND OF THE INVENTION
The present invention comprises a new class of compounds useful in treating diseases, such as TNF-.alpha., IL-1.beta., IL-6 and/or IL-8 mediated diseases and other maladies, such as pain and diabetes. In particular, the compounds of the invention are useful for the
BACKGROUND OF THE INVENTION
The present invention comprises a new class of compounds useful in treating diseases, such as TNF-.alpha., IL-1.beta., IL-6 and/or IL-8 mediated diseases and other maladies, such as pain and diabetes. In particular, the compounds of the invention are useful for the
BACKGROUND OF THE INVENTION
The present invention comprises a new class of compounds useful in treating diseases, such as TNF-.alpha., IL-1.beta., IL-6 and/or IL-8 mediated diseases and other maladies, such as pain and diabetes. In particular, the compounds of the invention are useful for the